Cenra Inc. (3716.TW)
Taiwan · TWD · Healthcare · Medical Distribution
NT$33.70 (+0.15%) as of
Key statistics
- Market cap
- 4.95B
- P/E (TTM)
- 8.24
- EPS (TTM)
- 4.09
- Dividend yield
- 2.98%
- 52-week range
- 31.55 – 37.65
- Beta
- 0.24
- Revenue (TTM)
- 8.44B
- Profit margin
- 6.05%
- Volume
- 176.52k
About Cenra Inc.
Cenra Inc. engages in the research and development, manufacture, and sale of generic pharmaceutical and healthcare products for humans and animals. It provides CDMO services for internal and external partners; oral solids, injectables, specialty formulations, and APIs, supported by process development, scale-up, and regulatory support; oral solids, injectables, specialty formulations, and high-purity active pharmaceutical ingredients (APIs), supported by process development, scale-up, and regulatory support; distribution, and marketing for prescription drugs, OTC products, health supplements, personal care products, and medical devices;home care, caregiver training, and consulting for elderly support; develops and manufactures veterinary pharmaceuticals, and animal health products for livestock and companion animals and offers CDMO services for animal health partners. Cenra Inc. was founded in 2024 and is headquartered in Taipei, Taiwan.
- Sector
- Healthcare
- Industry
- Medical Distribution
- Headquarters
- Taipei, Taiwan
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.